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Background
In the gastrointestinal (GI) tract NO is produced by
nNOS and released from nerve varicosities to relax GI
smooth muscle. NO-sensitive guanylyl cyclase (NO-GC),
the receptor for NO, is expressed in at least two cell
types, smooth muscle cells (SMC) and interstitial cells
of Cajal (ICC). It is still unclear which of these cell
types acts as primary target for nerve-released NO. ICC
express much higher amounts of NO-GC than SMC
and may therefore scavenge NO. In these cells, the
amount of NO-GC as well as the type(s) of phospho-
diesterase(s) (PDE) present will influence strength and
duration of the cGMP signal. Thereby, the cGMP/
cAMP crosstalk in these cells will be affected.
Methods
To clarify the individual impact of cGMP and cAMP on
relaxation of gastrointestinal smooth muscle we used our
mouse lines lacking NO-GC in SMC and ICC. Isometric
force studies were performed to monitor the responsive-
ness to exogenous and endogenous NO in absence and
presence of blockers of PDE3 (milrinone) and PDE5 (silde-
nafil). Immunohistochemistry was employed to identify
PDE3/5 expression.
Results
PDE5 is expressed in both SMC/ICC and participates in
cGMP degradation. Inhibition of PDE5 by sildenafil
increases NO-induced relaxation. Surprisingly, inhibition
of PDE3 expressed in SMC and ICC led to a decrease in
NO-induced relaxation. We are currently investigating
the impact of cGMP/cAMP crosstalk via PDE3 on GI
smooth muscle relaxation.
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